Estel Bio Overview
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
1
Estel Bio General Information
Description
Developer of precision cell reprogramming technology designed to reverse organ damage. The company's platform utilizes molecular programming to reset cellular states and restore functional capacity in damaged tissues, providing precision cell reprogramming therapies and regenerative medicine solutions, enabling healthcare providers to treat organ injury by rejuvenating cellular identity and function.
Contact Information
Website
www.estel.bioCorporate Office
- New York, NY
- United States
Corporate Office
- New York, NY
- United States
Estel Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 01-Nov-2026 | Completed | Startup |
Estel Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 2048 Ventures | Venture Capital | Minority |
Estel Bio FAQs
-
Where is Estel Bio headquartered?
Estel Bio is headquartered in New York, NY.
-
What industry is Estel Bio in?
Estel Bio’s primary industry is Biotechnology.
-
Is Estel Bio a private or public company?
Estel Bio is a Private company.
-
What is Estel Bio’s current revenue?
The current revenue for Estel Bio is .
-
Who are Estel Bio’s investors?
2048 Ventures has invested in Estel Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process